KROS SBC to Revenue

Keros Therapeutics Inc · SBC to Revenue

KROS logo

KROS SBC to Revenue

Current (TTM)152.30%
KROS SBC/Revenue (0.81% → 152.30%)
High-resolution chart · PNG

KROS sbc to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Keros Therapeutics Inc SBC to Revenue — Annual fiscal periods
Period endingSBC to Revenue
11.7577%
982.3099%
19,048.3444%
0%
58.3184%
0%
0%
0.81%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.